Cell-Easy gets approval to manufacture stem cells

By The Science Advisory Board staff writers

June 10, 2020 -- Toulouse-based startup Cell-Easy has been approved to open a private stem cell manufacturing plant in France.

This makes Cell-Easy the only private pharmaceutical company able to manufacture stem cells on an industrial scale in France, according to the firm.

In other news, the company has signed its first partnership agreement with the University Hospital Center in Toulouse to produce mesenchymal stem cells sourced from qualified fat tissue. A first clinical trial is on its way to develop treatments to fight against Alzheimer's disease.

If you like this content, please share it with a colleague!

Related Reading

Shanghai Cell Therapy Group, USC partner for stem cell therapies
Shanghai Cell Therapy Group has partnered with a researcher from the University of Southern California (USC) to develop a way to culture hematopoietic...

Cellect to develop stem cell therapy for COVID-19
Cellect Biotechnology has inked an agreement with international collaborators to develop a stem cell therapy for COVID-19 disease.

Stem cell findings help researchers learn about early-onset Parkinson's
New research utilizing stem cells indicates that the metabolic processes that lead to young-onset Parkinson's disease could begin years before symptoms...

Forward-oriented gene therapy improves treatment for sickle cell disease
Researchers at the National Institutes of Health (NIH) have developed a new and improved viral vector that is up to 10 times more efficient at incorporating...